Human Technopole continues its dialogue with Italian Research Hospitals (IRCCS).
Milan, 15 January – Human Technopole is an open hub for the entire Italian scientific community. This is how Marco Simoni – President of Human Technopole – described the Foundation during the event “Le strategie di ricerca della Fondazione Human Technopole: quali opportunità per gli IRCCS della Lombardia“, held at Palazzo Italia and organized by Assolombarda.
President Marco Simoni, Maria Grazia Magro (Head of Strategy and Scientific Affairs of Human Technopole) and Giuseppe Testa (Head of Neurogenomics Centre) explained the next steps of Human Technopole to almost 40 Research Hospitals’ General Director and Scientific Directors including Maria Chiara Carrozza (Scientific Director of Fondazione Don Gnocchi ), Alberto Mantovani (Scientific Director of Humanitas) and Fabrizio Tagliavini (Scientific Director of the Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta). Sergio Dompé – Vice President Life Sciences, Assolombarda – underlined Human Technopole’s innovative scope, its impact on Lombardy’s economic income and expressed the strong contribution that Assolombarda wants to give to the IRCCSs of Lombardy.
Human Technopole’s openness, its positive effects for the whole country and common objectives with the IRCCSs are the concepts stressed in Marco Simoni’s speech; Maria Grazia Magro highlighted the dialogue carried out with the representatives of the Italian scientific community in the past months when more than half of the Italian IRCCSs were met individually by Human Technopole. Giuseppe Testa focused on the work of his centre and on the synergies that can be implemented with the scientific community in the near future.
Yesterday, Open HT was announced – the first event organized by Human Technopole addressed to the scientific community, which will be the first, shared occasion of systematic dialogue on the Foundation’s development strategies.
Share:
You could also like:
-
How SNAPc recruits human RNA polymerases at snRNA genes
Using advanced cryo-electron microscopy and cross-linking mass spectrometry, HT researchers provide unprecedented insight into how SNAPc works as a “dual recruiter” for RNA Polymerase II and III. The findings are published in Nature Communications.
-
Italy at the centre of the Genome of Europe project
The Human Technopole, ELIXIR Italia, the national node of the European life sciences research infrastructure coordinated by the National Research Council (CNR), and the Centro Cardiologico Monzino, as the Italian coordinating centre, have been selected as the Italian partners of Genome of Europe (GoE), the largest EU-funded genomic project, whose ultimate goal is to make […]
-
Human Technopole wins 2024 Oscar di Bilancio
On Friday 13 December, at Palazzo Mezzanotte in Milan, the Human Technopole Foundation’s ‘Integrated Report 2023’ received the Oscar di Bilancio in the social enterprises and non-profit organisations category. The award was presented to President Gianmario Verona, Elena Trovesi, Head of Administration, as well as the project leaders Giovanni Selmi, Head of Finance, and Alessandro […]
-
Mosaic Organoids to Study the Brains of Multiple Patients Simultaneously
An international team of scientists from Human Technopole and the University of Milan has developed and validated an innovative approach to studying human brain development across multiple individuals simultaneously using single organoids—laboratory models that replicate key cellular processes of human neurodevelopment. The research paves the way for in vitro population studies. Additionally, the scientists have developed a novel computational method to more accurately quantify the genetic identity of individual cells profiled from multiple individuals concurrently. The findings have been published in Nature Methods.
-
Cancer stem cell morphology predicts glioblastoma growth and resistance
Human Technopole researchers have identified adducin-γ (ADD3) as a crucial regulator of glioblastoma cancer stem cell morphology and intercellular bridges between tumour cells. These connections facilitate communication and allow tumour cells to share resources, evade chemotherapy, and survive in challenging conditions. The study has been funded by AIRC and the findings are published in Life Science Alliance.